Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children under two years old, resulting in significant morbidity and a heavy economic burden on healthcare ...

A new scoping review examines the impact of respiratory bacteria on the severity of respiratory syncytial virus (RSV) ...

Among adults aged 75 and older, RSV was linked to a substantial burden of hospitalizations, ICU admissions, and in-hospital deaths before vaccines were available.

Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study.

Two metro Detroit health systems are restricting visitors to slow the spread of flu, respiratory syncytial virus, better known as RSV, and COVID-19.

This is an informal term that has come about recently to highlight the four viruses that are currently circulating at very high levels in the community and causing illness. These viruses are ...

There’s just a high burden of illness right now, and a lot of it is respiratory. We’re seeing high rates of influenza type A and B, respiratory syncytial virus or RSV, and then COVID-19 as well.